Mandate

Vinge has advised Main Capital and Pointsharp in connection with their strategic acquisition of SecMaker

Pointsharp enables organizations to secure IT environments with a high-level of control for IT departments combined with an intuitive mobile user experience.

Pointsharp has a broad solution offering in the identity and access management market related to multi-factor authentication, secure access, user provisioning and password management. SecMaker is a leading security provider in complex system environments with a strong footprint in the healthcare and government sectors. The combination of Pointsharp and SecMaker creates a leading security software provider in the Swedish market with strong potential for future North-Western European growth.

Vinge’s team consisted of counsel Filip Öhrner and associates Vilhelm Rondahl, Gustav Lindgren (M&A), Ebba Svenburg (Employment), Karl-Hugo Engdahl (GDPR/IT), Rebecka Weitzberg (IP), Lisa Hörnqvist (Agreements) and VDR assistant Carl Bruneheim (VDR).

Related

Vinge has advised Morrow Bank in connection with its issuances of primary capital instruments (AT1) and tier 2 capital bonds (T2)

The issuances comprised perpetual AT1 bonds of NOK 300 million with a floating coupon of 3-month NIBOR + 425 basis points and a first call date in 2031, as well as subordinated Tier 2 bonds of SEK 200 million with a floating coupon of 3-month STIBOR + 325 basis points and a first call date in 2031. The bonds are intended to be admitted to trading on Nasdaq Stockholm.
July 03, 2026

Vinge advises Wihlborgs Fastigheter in connection with the financing of property acquisition valued at SEK 13.3 billion

Vinge advises Wihlborgs Fastigheter AB (publ) in connection with the financing of the acquisition of all of Castellum’s property holdings in Malmö, Lund and Helsingborg. The financing has been secured through Danske Bank, SEB and Swedbank.
June 29, 2026

Vinge advises Ambea on the public offer for Humana

Ambea AB (publ) has made a public offer for all shares in Humana AB. The offer values all shares in Humana at approximately SEK 2,96 billion. The consideration consists of a mix of shares, cash and a CVR (contingent value right).
June 29, 2026